Fig. 7From: Enhanced oral delivery of insulin via the colon-targeted nanocomposite system of organoclay/glycol chitosan/Eudragit®S100Hypoglycemic effect after oral or subcutaneous injection of each formulation in diabetic rats (mean ± SD, n = 3)Back to article page